Neukoplast

N/A

Report date: 2024/06/12 20:00:37

Base Information

Drug NameNeukoplast
Drug Alias NameaNK cellsNK-92 cellsActivated natural killer cell therapyNeukoplastCST-101 +[6] 
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsBone Marrow NeoplasmsPancreatic NeoplasmsHodgkin Disease +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRush UniversityNantkwest Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunitybio IncUniversity Health Network (Uhn)
Active IndicationsN/A
Inactive IndicationsBone Marrow NeoplasmsPancreatic NeoplasmsHodgkin Disease +[7] 

Other Information

ATC CodeN/A
Related LinksWikipedia